Patient preferences for empiric TB treatment initiation.
作者信息
Sung J, Musoke M, Baik Y, Twinamasiko A, Lamunu M, Nabacwa V, Sanyu A, Kityamuwesi A, Katamba A, Dowdy D W
机构信息
Johns Hopkins University School of Medicine, Division of Infectious Diseases, Baltimore, MD, USA;, Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.
Uganda Tuberculosis Implementation Research Consortium, Walimu, Kampala, Uganda.
出版信息
Int J Tuberc Lung Dis. 2025 Jan 1;29(1):38-40. doi: 10.5588/ijtld.24.0267.
Abstract
摘要
相似文献
1
Patient preferences for empiric TB treatment initiation.
Int J Tuberc Lung Dis. 2025 Jan 1;29(1):38-40. doi: 10.5588/ijtld.24.0267.
2
Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in Uganda.
PLoS One. 2013 Sep 6;8(9):e74023. doi: 10.1371/journal.pone.0074023. eCollection 2013.
3
Empiric tuberculosis treatment in South African primary health care facilities - for whom, where, when and why: Implications for the development of tuberculosis diagnostic tests.
PLoS One. 2018 Jan 24;13(1):e0191608. doi: 10.1371/journal.pone.0191608. eCollection 2018.
4
Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalised HIV-infected persons?
PLoS One. 2013;8(2):e54875. doi: 10.1371/journal.pone.0054875. Epub 2013 Feb 4.
5
Empiric TB Treatment of Severely Ill Patients With HIV and Presumed Pulmonary TB Improves Survival.
J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):297-303. doi: 10.1097/QAI.0000000000000970.
6
Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study.
Pan Afr Med J. 2016 Mar 31;23:154. doi: 10.11604/pamj.2016.23.154.7995. eCollection 2016.
7
Pathways to care and preferences for improving tuberculosis services among tuberculosis patients in Zambia: A discrete choice experiment.
PLoS One. 2021 Aug 31;16(8):e0252095. doi: 10.1371/journal.pone.0252095. eCollection 2021.
8
Urine Lipoarabinomannan Testing in Adults With Advanced Human Immunodeficiency Virus in a Trial of Empiric Tuberculosis Therapy.
Clin Infect Dis. 2021 Aug 16;73(4):e870-e877. doi: 10.1093/cid/ciab179.
9
Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden Settings.
Open Forum Infect Dis. 2022 Jul 3;9(7):ofac325. doi: 10.1093/ofid/ofac325. eCollection 2022 Jul.
10
"Allergic bronchopulmonary aspergillosis misdiagnosed as smear negative pulmonary tuberculosis; a retrospective study from Pakistan".
Ann Med Surg (Lond). 2021 Nov 11;72:103045. doi: 10.1016/j.amsu.2021.103045. eCollection 2021 Dec.
本文引用的文献
1
Treatment preferences among people at risk of developing tuberculosis: A discrete choice experiment.
PLOS Glob Public Health. 2024 Jul 19;4(7):e0002804. doi: 10.1371/journal.pgph.0002804. eCollection 2024.
2
Causes of pre-treatment loss to follow-up in patients with TB.
Public Health Action. 2022 Dec 21;12(4):148-152. doi: 10.5588/pha.22.0051.
3
Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda.
PLoS One. 2020 Nov 18;15(11):e0241611. doi: 10.1371/journal.pone.0241611. eCollection 2020.
4
A clinical score for identifying active tuberculosis while awaiting microbiological results: Development and validation of a multivariable prediction model in sub-Saharan Africa.
PLoS Med. 2020 Nov 10;17(11):e1003420. doi: 10.1371/journal.pmed.1003420. eCollection 2020 Nov.
5
Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective.
BMC Health Serv Res. 2020 Mar 4;20(1):162. doi: 10.1186/s12913-020-4997-x.
6
Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trial.
Lancet HIV. 2020 Jan;7(1):e27-e37. doi: 10.1016/S2352-3018(19)30266-8. Epub 2019 Nov 11.
7
Pre-treatment loss to follow-up of pulmonary tuberculosis patients in two regions of Cameroon.
Int J Tuberc Lung Dis. 2018 Apr 1;22(4):378-384. doi: 10.5588/ijtld.17.0676.
8
Barriers and facilitators to the uptake of tuberculosis diagnostic and treatment services by hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review of qualitative literature.
Lancet Infect Dis. 2017 May;17(5):e128-e143. doi: 10.1016/S1473-3099(16)30531-X. Epub 2017 Mar 11.
9
Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation.
PLoS One. 2017 Jan 9;12(1):e0168659. doi: 10.1371/journal.pone.0168659. eCollection 2017.
10
Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?
Eur Respir J. 2016 Aug;48(2):516-25. doi: 10.1183/13993003.00543-2016. Epub 2016 Jul 13.
Zotero 插件